HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

4- (4- methyl- 2- (methylamino)thiazol- 5- yl)- 2- (4- methyl- 3- (morpholinosulfonyl)phenylamino)pyrimidine- 5- carbonitrile

structure in first source

Also Known As:

CDKI-83

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrimidines: 510
    - 4-(4-methyl-2-(methylamino)thiazol-5-yl)-2-(4-methyl-3-(morpholinosulfonyl)phenylamino)pyrimidine-5-carbonitrile: 1
Organic Chemicals: 133
- Amides: 2428
  - Sulfonamides: 2809
    - 4-(4-methyl-2-(methylamino)thiazol-5-yl)-2-(4-methyl-3-(morpholinosulfonyl)phenylamino)pyrimidine-5-carbonitrile: 1
- Sulfur Compounds: 278
  - Sulfones: 534
    - Sulfonamides: 2809
      - 4-(4-methyl-2-(methylamino)thiazol-5-yl)-2-(4-methyl-3-(morpholinosulfonyl)phenylamino)pyrimidine-5-carbonitrile: 1

Experts

1.	Fischer, Peter M: 1 article (06/2012)
2.	Lam, Frankie: 1 article (06/2012)
3.	Liu, Xiangrui: 1 article (06/2012)
4.	Shi, Shenhua: 1 article (06/2012)
5.	Wang, Shudong: 1 article (06/2012)

Related Diseases

1.	Neoplasms (Cancer) 06/01/2012 - "These results suggest that combined inhibition of CDK9 and CDK1 may result in the effective induction of apoptosis and CDKI-83 has the potential to be developed as an anti-cancer agent."